Dafodil Neo

Description:
Dafodil Neo Pericardial Bioprosthesis is a Triple Composite biomechanically engineered valve. It combines the latest engineering advancements over the Dafodil valve along with the benefits of bovine pericardial tissue.

Dafodil Neo comes with certain enhancements in implantability (reduced profile and an extension holder handle) suitable for minimally invasive valve replacement.

A reduction in the sewing ring diameter ensures better utilisation of the patient annulus area that ultimately translates into better hemodynamics for the patient.

Dafodil Neo Aortic valve comes with a unique 17mm size offering (by prescription only) that is suited for narrow aortic annulus found in certain patients.

Pericardial tissue and Elgiloy stent material are both known for their optimal intrinsic properties for valve manufacture.

Integrated processes such as Unique Tissue fixation, Advanced Tissue Thickness Matching Technology for Uniformity, and Tissue Deflection Testing enable leaflets to be accurately matched.

Position-specific design answers the challenging requirements of the mitral & aortic position Unique Delivery System For Mitral Position with the new Active flex technology that helps in reducing the external stent post diameter to aid in valve placement in the mitral position.

Overview:
Dafodil Neo is an advanced medical device designed to meet the highest standards of performance and reliability. With cutting-edge engineering and precision design, Dafodil Neo ensures optimal outcomes for healthcare professionals and patients.

Key Features:
Advanced technology for improved performance.
High durability for long-term reliability.
Designed for ease of use in clinical environments.

Applications:
Dafodil Neo is tailored for use in [specify applications, e.g., surgical procedures, diagnostic systems].